was a broad term that encompassed lack of desire‚ lack of pleasure‚ and painful intercourse (Canner‚ 2011). FSD began as a disorder that had little to no organic evidence or medical discoveries to prove its existence‚ however‚ the FDA approved clinical trials for treatment anyway (Canner‚ 2011). The FDA approval catalyzed a number of drug companies
Premium Medicine Sexual arousal Sexual intercourse
RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
1. Identify the independent variable(s) and dependent variable(s) Both groups of participants in this clinical trial‚ the psychotherapy group alone and the psychotherapy plus medication group‚ received psychotherapy but only one group received medication as an adjunct. The independent variable (IV) in this trial is the medication administered to the combined group‚ psychotherapy is considered a constant variable since both groups received it‚ and either an increase‚ decrease‚ or no change with participant’s
Premium Major depressive disorder Scientific method Clinical trial
Chemistry Biocon Microbial Fermentation Biodiversity Bioprocessing o Development Clinigene Clinical Research Clinical Development Clinical Trials o Commercialization Biocon Generics‚ main contributor to revenue: Bulk of their revenues came from generics. A generic drug typically cost 20 per cent to 80 per cent less because the product was not burdened with legacy expenses of research‚ development‚ clinical trials and marketing. Patent of Plafactor: Biocon secured a U.S. patent for a reactor it developed
Premium Pharmaceutical industry Clinical trial Pharmacology
into production as soon as the last regulatory hurdle in the clinical trials has been passed. “The biotech industry is going to become similar to the electronics industry”‚ Hans Ole Voigt‚ General Manager of NNE®‚ believes. Biotech and pharmaceutical companies know that they will have to jump‚ almost overnight‚ from producing small amounts of a compound for a clinical trial to producing industrial quantities of the same substance if the trial is successful. Voigt explains: “A significant proportion of
Premium Pharmaceutical industry Project management Clinical trial
(biomarkers and personalized prescription). Next‚ the first generation of five DNA pharmacogenomic tests used in the clinical practice of psychiatry is briefly reviewed. Then the possible involvement of these pharmacogenomic tests in the exploration of early clinical proof of mechanism is described by using two of the tests and one example from the pharmaceutical industry (iloperidone clinical trials). The initial attempts to use other microarray tests (measuring RNA expression) as peripheral biomarkers for
Premium Pharmacology Clinical trial Pharmaceutical industry
evidence in prevention of VTE. However‚ it is necessary to evaluate the sources in regards to its validity‚ accuracy‚ reasonableness and support. Three articles focus on different implementations and interventions in preventing VTE through various clinical trials‚ guidelines‚ and practices to improve VTE prophylaxis. Credibility When evaluating sources it is important to consider the article’s information and the author of the article to be both authentic and reliable. In the Journal article‚ “Evidence-based
Premium Clinical trial Pulmonary embolism Vein
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
company is based on the ability of these functions to work together. The pharmaceutical companies rely on research and development to find new and innovation new drugs. In order for a drug to enter the market it must undergo a series of tests and clinical trials. There are phases the drug must go through and complete in order to meet the requirements of the FDA. The development of a drug is an ongoing journey‚ and it can take up to 12 years to develop a drug (Pharmaceutical Patents 2006). The pharmaceutical
Premium Food and Drug Administration Pharmaceutical industry Drug development
increased duration of mechanical ventilation‚ prolonged intensive care unit and hospital stay‚ and increased cost of hospitalisation. Both the Centers for Disease Control Guidelines and Pugin’s Clinical Pulmonary Infection Score (CPIS) criteria note that diagnosing VAP requires a combination of clinical signs‚ impaired gas exchange‚ radiological changes and positive microscopy to differentiate an episode of VAP from mere colonisation. In a resource-strapped environment‚ semi-quantitative analysis
Premium Pneumonia Antibiotic Intensive care medicine